AdvaMed SmartBriefDesigned specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. &nbsp;Click&nbsp; <a href='http://www.smartbrief.com/advamed/index.jsp?sb_code=rss'>here</a> to subscribe.http://www.smartbrief.com/news/advamed?sb_code=rsshttp://www.smartbrief.com/images/homepage/hed-smartbrief.gifAdvaMed SmartBriefhttp://www.smartbrief.com/news/advamed?sb_code=rssen-us20 May 2013 09:36:09 CDTThoratec gets FDA OK for heart-pump pocket controllerhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DB9BEC44B-A656-41FC-906D-3B8D4353C54F%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DB9BEC44B-A656-41FC-906D-3B8D4353C54F%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssThoratec has gained FDA approval for use of its pocket controller in patients implanted with its HeartMate II left ventricula -More- ]]>20 May 2013 09:36:09 CDTTop StoryQuest buys Concentra's clinical lab and toxicology assetshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D8EF56424-2AE4-475B-97EE-19D40F3B7A59%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D8EF56424-2AE4-475B-97EE-19D40F3B7A59%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssQuest Diagnostics has agreed to pay an undisclosed sum to acquire Concentra's clinical lab and toxicology business, the compa -More- ]]>20 May 2013 09:36:09 CDTBusiness & Market TrendsTexas cancer Dx company obtains $1.5M in funding roundhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DA79F07EF-F760-4FB3-AA77-6651D521EEC1%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DA79F07EF-F760-4FB3-AA77-6651D521EEC1%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssA regulatory filing disclosed that Castle Biosciences has secured $1.5 million in its latest funding round.  -More- ]]>20 May 2013 09:36:09 CDTBusiness & Market TrendsTelcare wins EU approval for cellular-enabled glucometerhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DAB7E2DCF-CF66-4295-B33A-F8B7782E71D6%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DAB7E2DCF-CF66-4295-B33A-F8B7782E71D6%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssTelcare has received the go-ahead in Europe to market its blood glucose meter, which already has marketing clearance in the U -More- ]]>20 May 2013 09:36:09 CDTInternational DevelopmentsChina moves to streamline medtech regulatory processhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D7C0B18A1-CCD8-48A5-A677-E35982871260%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D7C0B18A1-CCD8-48A5-A677-E35982871260%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssThe China Food and Drug Administration has adopted measures to enhance its process for medical device classification, includi -More- ]]>20 May 2013 09:36:09 CDTInternational DevelopmentsOncology Dx project could get $6M boost from Cancer Geneticshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DBE2F892B-78BC-4024-A87D-28FD592A36FA%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DBE2F892B-78BC-4024-A87D-28FD592A36FA%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssCancer Genetics is considering investing as much as $6 million, phased in over three years, into an initiative it launched wi -More- ]]>20 May 2013 09:36:09 CDTScience & HealthPreventice confirms commercial release of remote monitoring toolhttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D0163F923-3963-44BB-91DD-A9D5C42968EB%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D0163F923-3963-44BB-91DD-A9D5C42968EB%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssPreventice has made its BodyGuardian Remote Monitoring System commercially available.  -More- ]]>20 May 2013 09:36:09 CDTEmerging TechnologiesElekta lands first order in Puerto Rico for cancer devicehttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D81214C52-DE67-4260-85E1-804D4153ADBB%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D81214C52-DE67-4260-85E1-804D4153ADBB%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssElekta has deployed a unit of its Versa HD radiotherapy device at the Caribbean Imaging and Radiation Treatment Center in Pue -More- ]]>20 May 2013 09:36:09 CDTIndustry Service ProvidersLawmakers seek to ease sequester restriction on FDA user feeshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D1143BDC1-A67F-4776-8BAA-30C9DE7EEEBF%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3D1143BDC1-A67F-4776-8BAA-30C9DE7EEEBF%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssFDA Commissioner Dr.  -More- ]]>20 May 2013 09:36:09 CDTGovernment & RegulatoryFDA reclassifies ingestible event markers as Class II deviceshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DC2670043-9006-47A2-BBBC-F744401E686E%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DC2670043-9006-47A2-BBBC-F744401E686E%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssThe FDA has downgraded ingestible event markers, which are prescription devices used to document time-stamped events logged b -More- ]]>20 May 2013 09:36:09 CDTGovernment & RegulatoryAdvaMed 2013 Company Presentations deadline is May 24http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DDDE456D3-CC92-4D45-9E45-ACB4E10B56E5%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DDDE456D3-CC92-4D45-9E45-ACB4E10B56E5%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssGain maximum visibility for your company at AdvaMed 2013 by presenting to strategic investors and other potential partners wh -More- ]]>20 May 2013 09:36:09 CDTAdvaMed NewsMolecular Diagnostics and the Changing Landscape: Considerations and Implicationshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DEADFF390-5800-4504-B013-8A0DE134277E%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DEADFF390-5800-4504-B013-8A0DE134277E%26brief%3Dadvamed%26sb_code%3Drss%26%26campaign%3DrssWednesday, June 5 – Thursday, June 6Sheraton Crystal City, Arlington, Va.Attendees will participate in sessions ranging -More- 

Medical Director - Hometown Health
Renown

]]>20 May 2013 09:36:09 CDTAdvaMed NewsI regret nothing, says arrogance; I will regret nothing, says inexperience.http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DD9A456CB-2CA2-4AEC-827D-AE7D69940EC6%26brief%3Dadvamed%26sb_code%3Drss%26campaign%3Drsshttp://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3DB2ADEDE0-93E0-40FD-9898-F31CB4040A52%26copyid%3DD9A456CB-2CA2-4AEC-827D-AE7D69940EC6%26brief%3Dadvamed%26sb_code%3Drss%26campaign%3DrssMarie von Ebner-Eschenbach,Austrian writer -More- ]]>20 May 2013 09:36:09 CDTSmartQuote